Psyence Biomedical (PBM) Short Interest Ratio & Short Volume $0.07 0.00 (-4.90%) (As of 01:22 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Psyence Biomedical Short Interest DataPsyence Biomedical (PBM) has a short interest of 605,600 shares, representing 6.50% of the float (the number of shares available for trading by the public). This marks a 181.54% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 3.70 million shares to cover all short positions.Current Short Interest605,600 sharesPrevious Short Interest215,100 sharesChange Vs. Previous Month+181.54%Dollar Volume Sold Short$64,799.20Short Interest Ratio0.1 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares16,700,000 sharesFloat Size9,320,000 sharesShort Percent of Float6.50%Today's Trading Volume1,176,105 sharesAverage Trading Volume3,695,482 sharesToday's Volume Vs. Average32% Short Selling Psyence Biomedical? Sign up to receive the latest short interest report for Psyence Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPBM Short Interest Over TimePBM Days to Cover Over TimePBM Percentage of Float Shorted Over Time Ad Behind the MarketsA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as little as $16 and a brokerage account.Click here to get the ticker >>> Psyence Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024605,600 shares $64,799.20 +181.5%6.5%0.1 $0.11 9/30/2024215,100 shares $21,510.00 -44.0%2.3%0 $0.10 9/15/2024384,200 shares $59,935.20 +34.4%4.2%0.1 $0.16 8/31/2024285,900 shares $117,161.82 -58.7%3.8%0.1 $0.41 8/15/2024692,300 shares $366,088.24 -42.3%9.3%0.3 $0.53 7/31/20241,200,000 shares $708,000.00 +400.8%19.9%0.5 $0.59 7/15/2024239,600 shares $84,818.40 -36.8%5.1%0.4 $0.35 6/30/2024378,900 shares $113,670.00 +94.8%8.1%0.8 $0.30 6/15/2024194,500 shares $117,400.20 +15.6%4.1%0.4 $0.60 5/31/2024168,300 shares $126,225.00 -21.3%3.6%0.2 $0.75 5/15/2024213,800 shares $182,114.84 -15.0%4.6%0.1 $0.85 4/30/2024251,500 shares $226,224.25 +3.8%5.4%0.1 $0.90 4/15/2024242,300 shares $192,507.35 -27.7%5.2%0.1 $0.79 3/31/2024335,300 shares $382,242.00 +15.6%7.1%0.1 $1.14 3/15/2024290,100 shares $374,229.00 +259.9%6.2%0.1 $1.29 2/29/202480,600 shares $44,330.00 +42.9%1.7%0 $0.55 2/15/202456,400 shares $37,522.92 +944.4%7.1%0.5 $0.67 1/31/20245,400 shares $9,612.00 No Change0.7%0.1 $1.78 PBM Short Interest - Frequently Asked Questions What is Psyence Biomedical's current short interest? Short interest is the volume of Psyence Biomedical shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 605,600 shares of PBM short. 6.50% of Psyence Biomedical's shares are currently sold short. Learn More on Psyence Biomedical's current short interest. What is a good short interest percentage for Psyence Biomedical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.50% of Psyence Biomedical's floating shares are currently sold short. Is Psyence Biomedical's short interest increasing or decreasing? Psyence Biomedical saw a increase in short interest in October. As of October 15th, there was short interest totaling 605,600 shares, an increase of 181.5% from the previous total of 215,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Psyence Biomedical's float size? Psyence Biomedical currently has issued a total of 16,700,000 shares. Some of Psyence Biomedical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Psyence Biomedical currently has a public float of 9,320,000 shares. How does Psyence Biomedical's short interest compare to its competitors? 6.50% of Psyence Biomedical's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Psyence Biomedical: Guardion Health Sciences, Inc. (1.76%), Oncternal Therapeutics, Inc. (0.64%), NuCana plc (4.66%), Purple Biotech Ltd (1.00%), 180 Life Sciences Corp. (16.06%), Synaptogenix, Inc. (1.36%), Pasithea Therapeutics Corp. (2.84%), Processa Pharmaceuticals, Inc. (5.66%), Hepion Pharmaceuticals, Inc. (0.33%), CNS Pharmaceuticals, Inc. (3.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Psyence Biomedical stock? Short selling PBM is an investing strategy that aims to generate trading profit from Psyence Biomedical as its price is falling. PBM shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Psyence Biomedical? A short squeeze for Psyence Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBM, which in turn drives the price of the stock up even further. How often is Psyence Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBM, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies GHSI Short Squeeze ONCT Short Squeeze NCNA Short Squeeze PPBT Short Squeeze ATNF Short Squeeze SNPX Short Squeeze KTTA Short Squeeze PCSA Short Squeeze HEPA Short Squeeze CNSP Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBM) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredMike Huckabee's Urgent Warning: Safeguard Your Financial Future NowMike Huckabee's Urgent Warning: Safeguard Your Financial Future NowAmerican Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.